Hemangiosarcoma Research Findings (Part 1)

Hemangiosarcoma is a common, highly aggressive cancer in dogs. This webinar reviews clinical trial findings for different treatment modalities as well as promising research directions for helping extend survival for canine patients. Discussions cover: *Different chemotherapy treatments *Muramyl Tripeptide Immunotherapy (L-MTP-PE) *eBAT *Propranolol with doxorubicin *EGFR/HER2 peptide vaccine immunotherapy *Early Detection of HSA *Monitoring disease progression with blood tests including NuQ Test **The information in this video is intended for educational and informational purposes only. It should not be considered a substitute for professional veterinary advice. *** ------- About Us The Canine Cancer Alliance (CCA) is a 501(c)3 nonprofit foundation with a mission to end dog cancer as we know it today. CCA funds research seeking cancer prevention and cures for our beloved pets. CCA also shares information about research and clinical studies enrolling canine patients. 🐾https://www.ccralliance.org/ CCA-funded research is 100% supported by donations. ❤️Donate here https://givebutter.com/CCAUnleashHope 🐾Start a Facebook Fundraiser:   / caninecanceralliance   🐶Start a Fundraiser in honor of your beloved pet https://givebutter.com/tributetails 🚗Consider donating a vehicle https://www.ccralliance.org/donate-a-...